Cosciens Biopharma Inc
(CSCI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 05-1995 | 02-1995 | 11-1994 | 05-1994 | 02-1994 | |
| Gross Profit | 1,372 | 1,088 | 1,090 | 1,028 | 459 |
| Operating Expenses | 10 | 7 | 10 | 11 | 12 |
| Operating Income | -10 | -7 | -10 | -11 | -12 |
| Pre-tax Income | -10 | -7 | -10 | -11 | -12 |
| Net Income Continuous | -10 | -7 | -10 | -11 | -12 |
| Net Income | $-10 | $-7 | $-10 | $-11 | $-12 |
| EBITDA(a) | $-10 | $-7 | $-10 | $-11 | $-12 |